Grifols SA SEC filings GRFS
Grifols SA has 463 filings in SEC EDGAR's recent list, going back to Oct 20, 2008. Its latest annual report, Form 20-F, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Oct 1, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 30, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| EFFECT | Filing | Apr 23, 2015 | — |
| CORRESP | Letter to the SEC | Apr 21, 2015 | — |
| CORRESP | Letter to the SEC | Apr 10, 2015 | — |
| CORRESP | Letter to the SEC | Apr 10, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2015 | — |
| CT ORDER | Filing | Jun 30, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2013 | — |
| CORRESP | Letter to the SEC | Jul 9, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2013 | — |
| CORRESP | Letter to the SEC | May 28, 2013 | — |
| UPLOAD | Letter from the SEC | May 14, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2012 | — |
| CORRESP | Letter to the SEC | Jul 13, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 5, 2012 | — |
| CORRESP | Letter to the SEC | Jun 11, 2012 | — |
| UPLOAD | Letter from the SEC | May 25, 2012 | — |
| EFFECT | Filing | Nov 9, 2011 | — |
| CORRESP | Letter to the SEC | Nov 8, 2011 | — |
| CORRESP | Letter to the SEC | Nov 7, 2011 | — |
| CORRESP | Letter to the SEC | Nov 7, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2011 | — |
| CERTNAS | Auto-generated paper document | Jun 1, 2011 | — |
| 8-A12B | Form 8-a12b | Jun 1, 2011 | — |
| EFFECT | Filing | Mar 14, 2011 | — |
| EFFECT | Filing | Jan 14, 2011 | — |
| CORRESP | Letter to the SEC | Jan 13, 2011 | — |
| CORRESP | Letter to the SEC | Jan 6, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2011 | — |
| CORRESP | Letter to the SEC | Dec 20, 2010 | — |
| CORRESP | Letter to the SEC | Nov 22, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2010 | — |
| CORRESP | Letter to the SEC | Nov 4, 2010 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2010 | — |
| CORRESP | Letter to the SEC | Oct 4, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2010 | — |
| EFFECT | Filing | May 26, 2009 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC)
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438569
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.